Financial statements Ozein Bio-Technology Ltd.

Balance sheet of Ozein Bio-Technology Ltd.

Company age:
Age:
9 y. 3 m. 27 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of OZEIN BIO-TECHNOLOGY LTD.

Year
2019
2020
2021
2022
Total assets 7 899 858,76 7 643 690,63 7 706 714,96 7 439 516,50
A. Fixed assets 5 870 246,92 6 338 347,09 6 260 086,11 6 086 983,07
B. Current assets 2 029 611,84 1 305 343,54 1 446 628,85 1 352 533,43
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 7 899 858,76 7 643 690,63 7 706 714,96 7 439 516,50
A. Equity 4 608 100,26 5 473 254,88 5 506 878,30 5 016 394,90
B. Liabilities and provisions for liabilities 3 291 758,50 2 170 435,75 2 199 836,66 2 423 121,60
I. Long-term liabilities 0,00 0,00 0,00 0,00
II. Short-term liabilities 3 291 758,50 2 170 435,75 2 199 836,66 2 423 121,60
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.